Oct 17, 2022· Comment from Association for Accessible Medicines (AAM)· FDA-2022-N-1633-0009
Comments submitted by Association for Accessible Medicines (AAM)
FDANonrulemakingFDA-2022-N-1633
Soliciting Public Comment on Appendix A of FDAs July 2018 Guidance Entitled ANDA Submissions Amendments to Abbreviated New Drug Applications Under GDUFA; Notice; Establishment of a Public Docket; Request for Comments
RIN
—
Last modified
Oct 17, 2022
Comment window
closed 1383d ago
Association for Accessible Medicines filings
1
Activity
Association for Accessible Medicines filed 1 comment on this docket between Oct 17, 2022 and Oct 17, 2022. 0 other organizations filed here. The comment window closed 1383d ago.
What Association for Accessible Medicines filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (0)
See everyone who commented →- Association for Accessible MedicinesTHIS ORG1 filing · confidence 97%